John Trizzino, EVP, CMO and CBO at NOVAVAX INC (NVAX), sold 27,420 shares at $114.25 ($3.1M) on 2021-01-05, disclosed to the SEC on 2021-01-07.
Open-market sale of $3.1M NVAX by EVP, CMO and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.25 | 3,700 | $408K | 13.2% |
| 2 | $111.19 | 4,164 | $463K | 15.0% |
| 3 | $111.19 | 4,164 | $463K | 15.0% |
| 4 | $112.19 | 4,194 | $471K | 15.3% |
| 5 | $112.19 | 4,194 | $471K | 15.3% |
| 6 | $113.29 | 3,500 |
| $397K |
| 12.9% |
| 7 | $114.25 | 1,500 | $171K | 5.6% |
| 8 | $115.11 | 349 | $40K | 1.3% |
| 9 | $116.24 | 59 | $7K | 0.2% |
| 10 | $116.24 | 584 | $68K | 2.2% |
| 11 | $124.17 | 506 | $63K | 2.0% |
| 12 | $124.17 | 506 | $63K | 2.0% |
| Total | $112.45 avg | 27,420 | $3.1M | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |